HEART FAILURE - ADULT (HF) -> HF - Therapeutics and Pharmacology Abstracts

110 - Impact of Immunosuppression on Acute Left Ventricular Function Recovery and ECMO Use in Patients with Fulminant Viral Myocarditis: An “All-In” Strategy

Presentation Number
110
Speakers
Session Name
SESSION 31 - ORAL: The Four-Letter Words of Shock: ECMO, PAPI, IABP and More
Date
Thu, Apr 23, 2020
Time
02:00 PM - 03:45 PM
Authors

Previous ePresentation
108 - Hemodynamic Effects of Sacubitril-Valsartan in Heart Failure with Reduced-Ejection Fraction: Are All Doses Created Equal?

Next ePresentations
116 - Impact of Ambient Particulate Matter (PM) Exposure of Lung Donors and Recipients on Bronchiolitis Obliterans Syndrome (BOS) and Mortality after Lung Transplant (LT)
119 - Transcriptome Analysis of Airway Brushes in Lung Transplant Recipients with and without Chronic Lung Allograft Dysfunction
121 - Mapping the Injury Phenotypes of Heart Transplant
123 - Upregulation of Class II HLA as a Marker of Antibody-Mediated Rejection in Heart Allografts
126 - Different Chronic Allograft Pathology Lesions in Two Orthotopic Lung Transplant Rat Strain Combinations
141 - CD26/DPP4 Inhibitor: A Novel Prophylactic Drug for Chronic Allograft Dysfunction after Clinical Lung Transplantation
148 - Development and Utility of a Novel Post-Operative Pediatric Heart Transplant Clinical Pathway
161 - The Impact of Local Heart Allocation on Post-Transplant Survival
163 - Early IVUS-Guided Selection for Non-Invasive Cardiac Allograft Vasculopathy (CAV) Screening in Heart Transplant Recipients
168 - Assessment of Cardiac Allograft Vasculopathy from Oct Images: Automated Analysis is as Good as Expert-Guided Approach